HEPION PHARMACEUTICALS INC (HEPA)
US4268973025 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 104.07% | N/A 52.99% | N/A 35.94% | |||||||||||
| EBITDA YoY % growth | -1.67M | -13.94M -734.73% | -20.79M -49.14% | -20.99M -0.96% | -14.57M 30.59% | -7.74M 46.88% | -20.12M -159.95% | -30.31M -50.65% | -43.54M -43.65% | -45.191M -3.79% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.67M | -13.96M -735.93% | -20.81M -49.07% | -21.02M -1.01% | -14.59M 30.59% | -7.77M 46.74% | -20.15M -159.33% | -30.4M -50.87% | -43.62M -43.49% | -45.258M -3.76% | N/A -16.18% | N/A -58.49% | N/A -10.77% | N/A -96.69% | N/A 29.94% | N/A 24.46% | N/A 62.21% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A -4.52% | -2.53 97.56% | N/A -254.78% | -11.80 -31.46% | -12.32 -4.41% | N/A 5.37% | N/A 54.51% | N/A -24.04% | N/A 1.71% | N/A 25.87% | N/A 24.47% | N/A 63.66% | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -1.68 30.45% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -19.278M -167.06% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -2.42 6.92% | -2.68 | 0.26 | 9.79% |
| Q3 2023 Q2Q % growth | -2.74 -24.55% | -3.18 | 0.44 | 13.90% |
| Q2 2023 Q2Q % growth | -3.68 29.23% | -3.39 | -0.29 | -8.56% |
| Q1 2023 Q2Q % growth | -3.48 -93.33% | -3.67 | 0.19 | 5.23% |
| Q4 2022 Q2Q % growth | -2.60 -1.96% | -2.65 | 0.05 | 1.96% |
| Q3 2022 Q2Q % growth | -2.20 -1,035.19% | -3.47 | 1.27 | 36.56% |
| Q2 2022 Q2Q % growth | -5.20 -5,100.00% | -2.45 | -2.75 | -112.42% |
| Q1 2022 Q2Q % growth | -1.80 -1,400.00% | -2.65 | 0.85 | 32.13% |
| Q4 2021 Q2Q % growth | -2.55 -779.31% | -2.45 | -0.10 | -4.17% |
| Q3 2021 Q2Q % growth | 71.91% | -0.19 | % | |
| Q2 2021 Q2Q % growth | -0.10 82.76% | -0.19 | 0.09 | 48.40% |
| Q1 2021 Q2Q % growth | -0.12 87.63% | -0.20 | 0.08 | 41.18% |
| Q4 2020 Q2Q % growth | -0.29 45.28% | -0.21 | -0.08 | -38.69% |
| Q3 2020 Q2Q % growth | -0.69 -30.19% | -0.52 | -0.17 | -32.64% |
| Q2 2020 Q2Q % growth | -0.58 | -0.51 | -0.07 | -13.73% |
| Q1 2020 Q2Q % growth | -0.97 | -0.26 | -0.72 | -280.39% |
| Q4 2019 Q2Q % growth | -0.53 | -0.98 | 0.45 | 46.15% |
| Q3 2019 Q2Q % growth | -0.53 | -0.65 | 0.12 | 18.81% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |